InsidersTradesSigma
Follow the INNO GENE S.A. stock price and the full management transaction log of the company, a listed issuer based in Poland. Shares trade on the PL market, under the supervision of KNF. Operating in the Health Care sector, INNO GENE S.A. has published 1 public disclosures. Market capitalisation: €29m. The latest transaction was disclosed on 18 May 2026 (Notification PDMR). Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
INNO GENE S.A. 是一家专注于医疗保健和制药领域的公司。该公司在 XWAR 市场上市。